Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Effective Dose Equivalent on the Ninth Shuttle: Mir Mission (STS-91)

Hiroshi Yasuda, Gautam D. Badhwar, Tatsuto Komiyama and Kazunobu Fujitaka
Radiation Research
Vol. 154, No. 6 (Dec., 2000), pp. 705-713
Stable URL: http://www.jstor.org/stable/3580617
Page Count: 9
  • Read Online (Free)
  • Download ($10.00)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Effective Dose Equivalent on the Ninth Shuttle: Mir Mission (STS-91)
Preview not available

Abstract

Organ and tissue doses and effective dose equivalent were measured using a life-size human phantom on the ninth Shuttle-Mir Mission (STS-91, June 1998), a 9.8-day spaceflight at low-Earth orbit (about 400 km in altitude and 51.65° in inclination). The doses were measured at 59 positions using a combination of thermoluminescent dosimeters of ${\rm Mg}_{2}{\rm SiO}_{4}\colon {\rm Tb}$ (TDMS) and plastic nuclear track detectors (PNTD). In correcting the change in efficiency of the TDMS, it was assumed that reduction of efficiency is attributed predominantly to HZE particles with energy greater than 100 MeV $\text{nucleon}^{-1}$. A conservative calibration curve was chosen for determining LET from the PNTD track-formation sensitivities. The organ and tissue absorbed doses during the mission ranged from 1.7 to 2.7 mGy and varied by a factor of 1.6. The dose equivalent ranged from 3.4 to 5.2 mSv and varied by a factor of 1.5 on the basis of the dependence of Q on LET in the 1990 recommendations of the ICRP. The effective quality factor $(Q_{e})$ varied from 1.7 to 2.4. The dose equivalents for several radiation-sensitive organs, such as the stomach, lung, gonad and breast, were not significantly different from the skin dose equivalent $(H_{\text{skin}})$. The effective dose equivalent was evaluated as 4.1 mSv, which was about 90% of the $H_{\text{skin}}$.

Page Thumbnails

  • Thumbnail: Page 
705
    705
  • Thumbnail: Page 
706
    706
  • Thumbnail: Page 
707
    707
  • Thumbnail: Page 
708
    708
  • Thumbnail: Page 
709
    709
  • Thumbnail: Page 
710
    710
  • Thumbnail: Page 
711
    711
  • Thumbnail: Page 
712
    712
  • Thumbnail: Page 
713
    713